invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs

invoX Pharma (“invoX”), a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK), focused on research and development (R&D) and business development activities outside of China, and F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX), a clinical-stage biopharmaceutical company ...

Related Keywords

China ,Delaware ,United States ,United Kingdom ,Sino Biopharm ,Ben Toogood ,Eliot Forster ,Therapeutics Inc ,Sino Biopharmaceutical Limited Biopharm ,Nasdaq ,Sino Biopharmaceutical Limited ,F Star Therapeutics ,F Star Boards ,Chief Executive Officer ,Hart Scott Rodino Antitrust Improvements Act ,